His scientific interests lie mostly in Immune system, Immunology, Virology, Antigen and DNA vaccination. Jean D. Boyer studies Humoral immunity which is a part of Immune system. In general Immunology study, his work on Acquired immune system, Immunotherapy and CTL* often relates to the realm of CD80 and Standardization, thereby connecting several areas of interest.
His Virology study integrates concerns from other disciplines, such as Cellular immunity, Viral vector, Immunization and DNA. Jean D. Boyer has researched Antigen in several fields, including T cell and Antibody. His DNA vaccination research is multidisciplinary, relying on both Adjuvant, Immunity, Immunogenicity and Vaccination.
Jean D. Boyer mainly focuses on Immunology, Immune system, Virology, DNA vaccination and Vaccination. The Immune system study combines topics in areas such as Viral replication and Antigen. His Antigen research is multidisciplinary, incorporating elements of Dysplasia and Recombinant DNA.
His work deals with themes such as Immunization and Immunity, which intersect with Virology. His study in DNA vaccination is interdisciplinary in nature, drawing from both Interleukin 12, Adjuvant, HIV vaccine and AIDS Vaccines. He has included themes like HIV Antigens, Seroconversion, DNA and Immunogen in his Vaccination study.
The scientist’s investigation covers issues in Immunogenicity, Internal medicine, Immune system, Immunotherapy and Oncology. Jean D. Boyer works mostly in the field of Immunogenicity, limiting it down to topics relating to DNA vaccination and, in certain cases, Vaccination, Virology, HIV vaccine, Ebola virus and Clinical trial. His Internal medicine research includes elements of ELISPOT and Seroconversion.
His Immune system study deals with the bigger picture of Immunology. His Immunotherapy study combines topics from a wide range of disciplines, such as Cancer research and Antigen. His Oncology study also includes
Internal medicine, Immunogenicity, Tolerability, Adverse effect and Immunotherapy are his primary areas of study. Jean D. Boyer regularly ties together related areas like DNA vaccination in his Immunogenicity studies. Jean D. Boyer combines subjects such as Regimen, Ebola virus, Virology and Zika virus with his study of DNA vaccination.
While the research belongs to areas of Adverse effect, Jean D. Boyer spends his time largely on the problem of Vaccination, intersecting his research to questions surrounding Clinical trial. His study with FOXP3 involves better knowledge in Immune system. His Cancer study frequently links to related topics such as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene inoculation generates immune responses against human immunodeficiency virus type 1.
Bin Wang;Kenneth E. Ugen;Vasantha Srikantan;Michael G. Agadjanyan.
Proceedings of the National Academy of Sciences of the United States of America (1993)
First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response
Rob Roy MacGregor;Jean D. Boyer;Kenneth E. Ugen;Kim E. Lacy.
The Journal of Infectious Diseases (1998)
Gene transfer in humans using a conditionally replicating lentiviral vector
Bruce L. Levine;Laurent M. Humeau;Jean Boyer;Rob-Roy MacGregor.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.
Cornelia L Trimble;Matthew P Morrow;Kimberly A Kraynyak;Xuefei Shen.
The Lancet (2015)
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.
Jean D. Boyer;Kenneth E. Ugen;Bin Wang;Michael Agadjanyan.
Nature Medicine (1997)
In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.
Jong J. Kim;Velpandi Ayyavoo;Mark L. Bagarazzi;Michael A. Chattergoon.
Journal of Immunology (1997)
CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.
Jong J. Kim;Liesl K. Nottingham;Jeong I. Sin;Anthony Tsai.
Journal of Clinical Investigation (1998)
Modulation of amplitude and direction of in vivo immune responses by co‐administration of cytokine gene expression cassettes with DNA immunogens
Jong J. Kim;Neil N. Trivedi;Liesl K. Nottingham;Lake Morrison.
European Journal of Immunology (1998)
Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
Mark L. Bagarazzi;Jian Yan;Matthew P. Morrow;Xuefei Shen.
Science Translational Medicine (2012)
Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
Jong J. Kirn;Mark L. Bagarazzi;Neil Trivedi;Yin Hu.
Nature Biotechnology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: